|Prima Biomed Ltd -- USA Stock|| |
USD 2.24 0.12 5.08%
Member of the Clinical Advisory BoardWe currently do not have informatin regarding Bradley Monk. This executive tanure with Prima Biomed Ltd is not currenlty determined.
Executive Since 2014
61 2 8315 7003 http://www.primabiomed.com.au
The company has return on total asset (ROA)
of (15.25) %
which means that it has lost $15.25 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (30.29) %
meaning that it created substantial loss on money invested by shareholders.
The company currently holds 4.65 M in liabilities with Debt to Equity (D/E) ratio of 21.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Prima Biomed Ltd has Current Ratio of 5.93 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.
Prima BioMed Ltd. engages in the research, development, and commercialization of medical biotechnology solutions in Australia. Prima Biomed Ltd (PBMD) is traded on NASDAQ General Markets in USA. It is located in AUSTRALIA and employs 31 people. Prima Biomed is listed under Pharmaceutical Products category by Fama And French industry classification.